Echo Therapeutics (ECTE)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Sep 2, 2021 03:12 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Echo Therapeutics Inc. [ECTE]
Reports for Purchase
Showing records 21 - 30 ( 30 total )
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Q4 2011 earnings inline, critical care pilot study results soon
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Echo announces positive results in pilot study of diabetics and additional financing
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ECTE Q3 earnings better than expected, pilot studies continue
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
The Truffle Shuffle-Diabetes Edition: Investment Implications of Obesity on Diabetes Devices
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Q2 earnings inline, Prelude 510(k) amendment and Symphony pilot studies soon
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
ValuEngine Detailed Valuation Report for ECTE
Provider: VALUENGINE, INC
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
No news is bad news? Fundamentals intact, reiterating STRONG BUY, $6.50 PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Echo Therapeutics Inc.
Industry: Medical - Instruments
From Prelude to Symphony; initiating with STRONG BUY, $6.50 PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B